Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Zander

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 17, 2009
HLA-mismatched unrelated donors as an alternative graft source for allogeneic stem cell transplantation after antithymocyte globulin-containing conditioning regimenNicolaus Kröger, Tatjana Zabelina, Thomas Binder, et al.
Experimental Hematology|November 3, 2007
Rapid regression of bone marrow fibrosis after dose-reduced allogeneic stem cell transplantation in patients with primary myelofibrosisNicolaus Kröger, Jürgen Thiele, Axel Zander, et al.
Experimental Hematology|October 23, 2012
Postallograft lenalidomide induces strong NK cell-mediated antimyeloma activity and risk for T cell-mediated GvHD: Results from a phase I/II dose-finding studyChristine Wolschke, Thomas Stübig, Ute Hegenbart, et al.
Blood|February 21, 2009
JAK2-V617F-triggered preemptive and salvage adoptive immunotherapy with donor-lymphocyte infusion in patients with myelofibrosis after allogeneic stem cell transplantationNicolaus Kröger, Haefaa Alchalby, Evgeny Klyuchnikov, et al.
Stem Cells and Development|June 23, 2005
Reduction of myocardial scar size after implantation of mesenchymal stem cells in rats: what is the mechanism?Kai Jaquet, Korff T Krause, Joachim Denschel, et al.
British Journal of Haematology|February 24, 2005
Pilot study of reduced-intensity conditioning followed by allogeneic stem cell transplantation from related and unrelated donors in patients with myelofibrosisNicolaus Kröger, Tatjana Zabelina, Heike Schieder, et al.
Blood|March 7, 2007
Proteomic patterns predict acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantationEva M Weissinger, Eric Schiffer, Bernd Hertenstein, et al.
Haematologica|June 17, 2008
Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow TransplantationAndré Tichelli, Jakob Passweg, Dorota Wójcik, et al.
Haematologica|July 6, 2005
Development of leukemia in donor cells after allogeneic stem cell transplantation--a survey of the European Group for Blood and Marrow Transplantation (EBMT)Bernd Hertenstein, Lothar Hambach, Andrea Bacigalupo, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 20, 2010
Purification of CD4+ T cells for adoptive immunotherapy after allogeneic hematopoietic stem cell transplantationEvgeny Klyuchnikov, Andreas Sputtek, Olga Slesarchuk, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 17, 2009
HLA-mismatched unrelated donors as an alternative graft source for allogeneic stem cell transplantation after antithymocyte globulin-containing conditioning regimenNicolaus Kröger, Tatjana Zabelina, Thomas Binder, et al.
Experimental Hematology|November 3, 2007
Rapid regression of bone marrow fibrosis after dose-reduced allogeneic stem cell transplantation in patients with primary myelofibrosisNicolaus Kröger, Jürgen Thiele, Axel Zander, et al.
Experimental Hematology|October 23, 2012
Postallograft lenalidomide induces strong NK cell-mediated antimyeloma activity and risk for T cell-mediated GvHD: Results from a phase I/II dose-finding studyChristine Wolschke, Thomas Stübig, Ute Hegenbart, et al.
Blood|February 21, 2009
JAK2-V617F-triggered preemptive and salvage adoptive immunotherapy with donor-lymphocyte infusion in patients with myelofibrosis after allogeneic stem cell transplantationNicolaus Kröger, Haefaa Alchalby, Evgeny Klyuchnikov, et al.
Stem Cells and Development|June 23, 2005
Reduction of myocardial scar size after implantation of mesenchymal stem cells in rats: what is the mechanism?Kai Jaquet, Korff T Krause, Joachim Denschel, et al.
British Journal of Haematology|February 24, 2005
Pilot study of reduced-intensity conditioning followed by allogeneic stem cell transplantation from related and unrelated donors in patients with myelofibrosisNicolaus Kröger, Tatjana Zabelina, Heike Schieder, et al.
Blood|March 7, 2007
Proteomic patterns predict acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantationEva M Weissinger, Eric Schiffer, Bernd Hertenstein, et al.
Haematologica|June 17, 2008
Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow TransplantationAndré Tichelli, Jakob Passweg, Dorota Wójcik, et al.
Haematologica|July 6, 2005
Development of leukemia in donor cells after allogeneic stem cell transplantation--a survey of the European Group for Blood and Marrow Transplantation (EBMT)Bernd Hertenstein, Lothar Hambach, Andrea Bacigalupo, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 20, 2010
Purification of CD4+ T cells for adoptive immunotherapy after allogeneic hematopoietic stem cell transplantationEvgeny Klyuchnikov, Andreas Sputtek, Olga Slesarchuk, et al.
Pageof 4